Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans
- PMID: 20956621
- PMCID: PMC3020699
- DOI: 10.1200/JCO.2010.31.2603
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans
Erratum in
- J Clin Oncol. 2011 Feb 20;29(6):779
Abstract
The merger of the Pediatric Oncology Group, Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, and the National Wilms Tumor Study Group in 2000 offered the newly formed Children's Oncology Group (COG), an opportunity to study rare cancers that had not been the subject of organized evaluation within the context of a cooperative group. In 2002, the COG formed the rare tumor committee which is comprised of four subcommittees. This article details the experience of the infrequent tumor subcommittee for the period of 2002 to 2007. During the initial implementation of this strategy, we have observed low rates of registration within the COG registry and low levels of participation in open banking, biology, and first-line therapeutic studies. This initial experience has allowed us to develop alternative strategies to increase registration rates and clinical trial enrollments. It is hoped that these new plans will allow us to increase our ability to better understand the biology and improve the treatment outcome of young patients with infrequent cancers. Furthermore, our initial experience has demonstrated to us the potential power of expanded cooperation and collaboration at a global level.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
Similar articles
-
The U.S. pediatric cancer clinical trials programmes: international implications and the way forward.Eur J Cancer. 1997 Aug;33(9):1439-47. doi: 10.1016/s0959-8049(97)00249-9. Eur J Cancer. 1997. PMID: 9337687 Review.
-
Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group.Semin Oncol. 2008 Oct;35(5):484-93. doi: 10.1053/j.seminoncol.2008.07.008. Semin Oncol. 2008. PMID: 18929147 Free PMC article. Review.
-
Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.Pediatr Blood Cancer. 2012 Jul 15;59(1):5-10. doi: 10.1002/pbc.24118. Epub 2012 Feb 29. Pediatr Blood Cancer. 2012. PMID: 22378628 Free PMC article. Review.
-
A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities.J Adolesc Young Adult Oncol. 2019 Jun;8(3):227-235. doi: 10.1089/jayao.2018.0119. Epub 2019 Jan 23. J Adolesc Young Adult Oncol. 2019. PMID: 30676208
-
Pediatric cancer research from past successes through collaboration to future transdisciplinary research.J Pediatr Oncol Nurs. 2004 May-Jun;21(3):123-7. doi: 10.1177/1043454204264406. J Pediatr Oncol Nurs. 2004. PMID: 15296038 Review.
Cited by
-
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.EJC Paediatr Oncol. 2023 Dec;2:100024. doi: 10.1016/j.ejcped.2023.100024. Epub 2023 Jul 20. EJC Paediatr Oncol. 2023. PMID: 37829670 Free PMC article.
-
Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.Small. 2023 Jul 30:e2301776. doi: 10.1002/smll.202301776. Online ahead of print. Small. 2023. PMID: 37518857 Review.
-
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.J Clin Oncol. 2023 Aug 20;41(24):4045-4053. doi: 10.1200/JCO.22.02208. Epub 2023 Jun 2. J Clin Oncol. 2023. PMID: 37267580 Free PMC article.
-
Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary.Front Oncol. 2021 May 10;11:590913. doi: 10.3389/fonc.2021.590913. eCollection 2021. Front Oncol. 2021. PMID: 34041014 Free PMC article.
-
Rare tumors in pediatric age group: Single center experience from Saudi Arabia.Rare Tumors. 2021 Feb 24;13:2036361321997331. doi: 10.1177/2036361321997331. eCollection 2021. Rare Tumors. 2021. PMID: 33708364 Free PMC article.
References
-
- Rare Disease Act of 2002: Public law act 107-280 November 6, 2002. http://history.nih.gov/research/downloads/PL107-280.pdf.
-
- Ries L, Smith M, Gurney J, et al. Bethesda, MD: National Cancer Institute, SEER program Pub No 99-4649; 1999. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995.
-
- Ferrari A, Bisogno G, De Salvo GL, et al. The challenge of very rare tumours in childhood: The Italian TREP project. Eur J Cancer. 2007;43:654–659. - PubMed
-
- International Classification of Childhood Cancer subgroup XI of the SEER database. http://seer.cancer.gov/csr/1975_2007/results_merged/sect_29_childhood_ca....
-
- Bleyer WA. Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002;38:1–10. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases